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Familial hyperinsulinism and pancreatic b-cell ATP-sensitive shows an increased glycemic response due to increased
potassium channels. Familial hyperinsulinism, also known as glycogen storage in the liver. After the diagnosis of PHHI
persistent hyperinsulinemic hypoglycemia of infancy (PHHI), has been established, immediate treatment is directedis a genetic disease characterized by mild to severe hypoglyce-
towards the maintenance of euglycemia usually by con-mia in the presence of inappropriately high levels of insulin.
tinuous administration of intravenous glucose at ratesThe recessive form is caused by mutations in the adenosine
59-triphosphate (ATP)-sensitive K1 channel (KATP channel) between 15 and 20 mg/kg/min. If hypoglycemia persists,
present in the plasma membrane of pancreatic b-cells. This the second line of treatment is the administration of com-
channel is formed by two subunits, the high-affinity sulfonyl- pounds that inhibit insulin secretion. Two compounds,urea receptor, SUR1, and KIR6.2, a member of the inwardly diazoxide and somatostatin (octreotide), are widely usedrectifying family of K1 channels. KATP channels regulate insulin
[4]. If this clinical treatment fails to normalize glucosesecretion by linking membrane excitability with glucose metab-
olism. Approximately 50 mutations, in both channel subunits, levels a partial or subtotal pancreatectomy becomes the
that abolish or alter the regulation of b-cell KATP channels have treatment of choice [1]. Mild forms of the disease may go
been identified in patients with the recessive form of PHHI. undiagnosed until eating habits change and an infant has
less frequent meals and thus becomes hypoglycemic. Di-
azoxide or octreotide for a few months may be sufficient
Persistent hyperinsulinemic hypoglycemia of infancy to normalize glucose levels, and clinical remission of symp-
(PHHI), also known as familial hyperinsulinism or nesi- toms with time has been observed [3]. In a follow-up
dioblastosis (OMIM:256450), is an inherited disorder of study on patients who were treated clinically, Leibowitz
glucose metabolism that presents in newborns and in- et al have shown that although patients appear to go into
fants, and is mainly characterized by inappropriately high remission, the beta cell defect remains and a significant
insulin levels in the presence of low levels of blood glu- number of these individuals become diabetic when they
cose. PHHI was originally thought to be a relatively ho- reach puberty [5].
mogenous disorder, but over the last several years an The frequency of the recessive form of PHHI in the
underlying heterogeneity has become clear [1]. It is now general population is low (1:50,000), but is reported to
understood that PHHI can present with a quite variable be as high as 1:2500 in inbred populations with a high
clinical picture, has at least two different histopathologic frequency of consanguineous marriages [6]. PHHI is ge-
forms, can be inherited in either a recessive or dominant netically heterogeneous. Four genes have now been iden-
manner, and can be caused by mutations in at least four tified to cause the disease, and in approximately 50% of
genes [2]. the cases that have been screened for the known reces-
From the clinical point of view, some patients present sive and dominant genes, the mutations have not been
with severe hypoglycemia almost immediately after birth, identified. Two mild dominant forms of PHHI have been
while others show mild hypoglycemia weeks or months described that are caused by mutations in the glucoki-
after birth [3]. A biochemical diagnosis is based on ab- nase and glutamate dehydrogenase genes, respectively.
normally high insulin levels in the presence of persisting Loss of function mutations in glucokinase have been
hypoglycemia, low ketone bodies (a result of their sup- identified as a cause of maturity-onset diabetes of the
pression by elevated insulin), and a glucagon test that young, MODY2 [7, 8]. Interestingly, a point mutation,
V455 M, in glucokinase has now been identified as caus-
ing one of the mild dominant forms of PHHI. This muta-Key words: insulin, potassium channel, sulfonylurea receptor, pan-
creas. tion produces an enzyme with a Km that is ,65% lower
in comparison with wild-type glucokinase (2.9 mmol/L vs.Ó 2000 by the International Society of Nephrology
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8.4 mmol/L). This better binding of glucose to glucoki- gene to the short arm of chromosome 11 (11p15.1). This
nase results in insulin release at a lower blood glucose location was within the region where previous family
concentration [9]. The second dominant form of PHHI studies by Ben Glaser, Heddy Landau, Alan Permutt [17,
presents with asymptomatic hyperammonemia and hy- 18] and Pamela Thomas [19] had localized the gene(s) for
poglycemia [1]. Five mutations in the glutamate dehy- the recessive form of PHHI. Subsequent studies showed
drogenase gene have been identified that give this pheno- that the SUR1 and KIR6.2 genes were clustered in this
type [10]. These dominant forms of PHHI respond to region (Fig. 1). This cluster has been completely se-
treatment with diazoxide indicating KATP channels are quenced and is available as part of the sequence of the
functional. The recessive and most common form of the chromosome 11p14.3 PAC clone, pDJ239b22 (Genbank
disease is caused by mutations in SUR1 and KIR6.2, the accession #s AC003969 & U90583). This clone contains a
subunits of the pancreatic b-cell ATP-sensitive K1 considerable amount of flanking sequence, which should
channel. facilitate investigation of the regulatory sequences that
From the histopathologic point of view, PHHI was control expression of these genes. The region specifying
initially thought to result from nesidioblastosis following both genes spans ,90 Kb of DNA. SUR1 (OMIM
the report by Brown and Young of neoformation of 600509) encodes the high affinity sulfonylurea receptor
islets in the pancreas of a newborn patient with severe (1581 or 1582 amino acids) [20]. The intronless KCNJ11
hypoglycemia [11]. Nesidioblastosis was used to identify gene encoding the 390 amino acid inward rectifier, KIR6.2
the disorder over the next decade, and it was not until (OMIM 600937), is 4900 base pairs 39 of the end of the
the early 1980s that Jaffe, Hashida and Yunis [12] and SUR1 gene [21]. A preliminary identification of the basal
Rahier et al [13], using specific staining techniques and promoter sequences is available [22]. We have compared
by studying age-matched controls, determined that nesi- the structure of the SUR1-KIR6.2 gene cluster with the
dioblastosis was present in both hypoglycemic and con- SUR2-KIR6.1 gene cluster elsewhere [23].
trol groups. Following these observations and confirma- A definitive connection between the recessive form of
tion of the lack of specificity of nesidioblastosis, others PHHI and KATP channels was made by Dunne et al, who
have identified nesidioblastosis in diseases like MEN1, demonstrated the absence of ATP-sensitive K1 channel
pancreatitis and cystic fibrosis. activity in the b-cells of a patient homozygous for a
Recent observations have identified at least two histo- mutation in exon 35 that resulted in truncation of SUR1
pathologic forms of PHHI: focal and diffuse [14]. The in the second nucleotide binding fold [24]. The patient
focal form is described by the presence of a well defined was not responsive to diazoxide, requiring continuous
area within normal pancreatic tissue showing b-cells with infusion of glucose (18 mg/kg/min) to remain euglycemic.
enlarged nuclei and increased cytoplasmic volume. En- Subtotal (95%) pancreatectomy did not significantly re-
larged cells with similar morphology, indicative of in- duce insulin levels and removal of 99% of the pancreas
creased metabolic and secretory activity, are widely scat- was necessary to control hypoglycemia. Electrical re-
tered throughout the pancreas in the diffuse form of cording from isolated b-cells from this patient failed to
PHHI. The differentiation of these two types is impor- show KATP channel activity while voltage-gated Ca21
tant as the focal form of the disease, present in ,30 to channels were spontaneously active. As in the five infants
50% of cases that require surgery, responds well to par- studied earlier [25], b-cell cytosolic Ca21 levels were ele-
tial rather than total pancreatectomy with the patient vated beyond control cell values (83 vs. 115 nmol/L) and
becoming euglycemic after removal of the hyperplastic this elevation was assumed to initiate insulin secretion.
lesion. Considerable effort is being directed at under- A parallel mutation engineered into hamster SUR1 failed
standing the origin of the focal form of PHHI. SUR1 to generate KATP channel activity when cotransfected intoand KIR6.2 map to a region of chromosome 11, where COS cells with wild-type KIR6.2. Biochemical studies onother genes show loss of heterozygosity as a result of
the parallel mutation showed the truncated receptor was
“imprinting.” In some cases of the recessive form of
produced and retained high affinity sulfonylurea bindingPHHI, loss of heterozygosity appears to result from a loss
activity. Preliminary results indicate that the truncatedof the maternal allele through a somatic deletion. PHHI
receptor is able to associate with and cophotolabel KIR6.2.can result when apparent homozygosity is achieved by
For the KIR6.2 gene, three mutations have been identi-combination of this imprinting effect with a genomic
fied that cause PHHI (Fig. 2). Thomas, Ye and Lightnermutation in either of the paternal SUR1 alleles. At this
first reported a KIR6.2 mutation, a leu!pro change,time, no mutations in KIR6.2 have been found that reach L147P, near the extracellular side of the second trans-the homozygous state by this mechanism [15, 16].
membrane helix (M2), to cause PHHI [26]. This mutation
was identified in a child of Iranian origin, the progeny
MUTATIONS IN SUR1 AND KIR6.2 of a first cousin marriage. Diagnosis of PHHI was based
on an insulin level of .30 mU/mL with a glucose levelThe first suggestion that the recessive form of PHHI
might be a channelopathy was the mapping of the SUR1 ,30 mg/dL and a requirement of .15 mg glucose kg/min
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Fig. 1. Human SUR1-KIR6.2 gene cluster. The 39 exons of the SUR1 gene are represented by the numbered light and dark boxes. The numbers
above each exon indicate the exon size in base pairs. NBF1 and NBF2 mark the nucleotide binding folds and their corresponding Walker A and
B motifs. The intronless KIR6.2 lies 39 of SUR1 as shown.
Fig. 2. Human KIR6.2 gene mutations. A sche-
matic representation of KIR6.2 in the plasma
membrane positioning the three known muta-
tions. The M1 and M2 identify the transmem-
brane helices. The H5 region identifies the K1
selective pore. (Figure modified from [2]; used
with permission).
to maintain euglycemia. Substitution of this proline into coexpressed with wild-type SUR1, KIR6.2W91R failed to
M2 abolishes KATP channel activity when it is engineered produce active channels.
into KIR6.2 and expressed with wild-type SUR1. It is not Fifty mutations in the SUR1 gene have been identified
clear if KIR6.2L147P can fold correctly and assemble with in PHHI patients. These mutations can be divided into
SUR1, as we have been unable to show co-photolabeling two main groups based on the severity of the disease
with 125I-iodoazidoglibenclamide (Aguilar-Bryan, unpub- (Fig. 3). Point mutations that result in amino acid substi-
lished data). tutions can produce mild forms of the disorder, while
Nestorowicz et al described a nonsense mutation in nonsense mutations or those that alter splice sites and
KIR6.2 that truncated the protein after 12 amino acids, result in truncation of the receptor are associated with
Y12X [27]. The patient was homozygous for this muta- severe cases.
tion. When Y12X was engineered into KIR6.2, as ex-
pected for a 12 residue peptide that is missing all of the
THE G1479R MUTATION IS AN EXAMPLE OFelements required to form the K1 channel pore, it did
THE MILD FORMnot form a functional channel when coexpressed with
Studies on cells expressing the G1479R missense mu-wild-type SUR1.
tant of SUR1, identified in a patient with a mild case ofSharma and Aguilar-Bryan have identified a third
familial hyperinsulinism, suggests adenosine 59-diphos-KIR6.2 mutant, a trp!arg change, W91R, near the exter-
phate (ADP) rather than ATP is the physiologic regulatornal side of M1 (unpublished data). This mutation was
of KATP channels [28]. This mutation in NBF2 was identi-identified in a newborn, the product of a first cousin
fied by Dr. Ann Nestorowicz in Dr. Alan Permutt’s labo-marriage of Palestinian descent. Clinical treatment with
ratory in a patient of Iraqi and Moroccan Jewish extrac-diazoxide and somatostatin was not successful and a par-
tion diagnosed with PHHI by Drs. Heddy Landau andtial pancreatectomy was performed at two weeks of age;
a second resection was necessary four weeks later. When Benjamin Glaser (Hebrew University, Hadassah Medi-
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Fig. 3. Human SUR1 gene mutations. A schematic representation of SUR1 and the SUR1 gene is shown. The receptor is on the top with the
predicted transmembrane domains (shaded boxes) and nucleotide binding folds illustrated for reference. The gene structure is given below. The
approximate positions of mutations within exons are shown, while the mutations within introns are given in italics at the bottom of the graphic
(figure modified from [2]; used with permission).
cal Center, Jerusalem). The patient is a compound het- TRUNCATIONS OF SUR1 MAY RESULT IN
DEFECTIVE TRAFFICKING OF KATPerozygote, with the G1479R allele on one chromosome
CHANNEL SUBUNITSand a second, unidentified allele on the other. In excised
membrane patches MgADP antagonizes the inhibitory A number of mutations identified with severe cases
of PHHI cause truncation of the receptor. As noted aboveaction of ATP on KATP channels. In the G1479R channels
for the exon 35 mutation reconstitution of the engineeredthis antagonizing action is strongly reduced [28]. Co-
mutant receptor with wild-type KIR6.2 does not produceexpression of SUR1G1479R with wild-type KIR6.2 produces
active KATP channels. The reason for this failure is notK1 channels that are inhibited by ATP 42, or MgATP,
clear. We have looked at recombinant receptors engi-in excised patches with nearly the same IC50 as native or
neered with smaller truncations (one example with 49wild-type reconstituted channels; however, these channels
amino acids truncated from the SUR1 C-terminus is shown
are poorly activated by MgADP [28]. The SUR1G1479R/ in Fig. 4) in order to determine whether smaller deletions
KIR6.2 channels are also poorly activated by conditions can be tolerated without loss of channel function. 86Rb1
of metabolic inhibition that strongly activate wild-type efflux data (Fig. 4A) show that deletion of 49 amino
channels. We have concluded that in PHHI b-cells the acids from the C-terminus of SUR1 reduces channel
G1479R channels are blocked by ATP and apparently activity to background levels equivalent to that observed
fail to respond to fluctuations in ADP. The result implies with SUR1 or KIR6.2 alone [21]. Comparison of the pho-
tolabeling pattern of the SUR1DC49 receptor with andthat fluctuations of [ATP]i alone are not sufficient to
without KIR6.2 indicates the truncated receptors havetrigger insulin secretion in either the recombinant chan-
not undergone maturation. This result suggests that trun-nels during metabolic inhibition or in PHHI patients and
cation of the C-terminus of SUR1 interferes with traf-indicate ADP is a critical factor. Approximately 25% of
ficking of the channel complex to the plasma membrane.the mutations identified in recessive cases of PHHI ap-
pear to have lost this stimulatory response to ADP
SUMMARY[2, 29]. Patients with these SUR1 mutations usually re-
spond well to a high carbohydrate diet, diazoxide or It is now understood that mutations in SUR1 and
KIR6.2 can result in the loss of KATP channel activity inoctreotide treatment.
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pancreatic b-cells and cause a recessive form of PHHI.
These results emphasize the important role of ionic
mechanisms in control of insulin secretion. Efforts to
understand how individual mutations result in loss of
channel activity provide insight into the molecular mech-
anism(s) of regulation of this family of channels and
their expression on the cell surface.
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